Skip to main content

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Landauer Radiopharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (13)
ARTG (3)

Date

2024 (2)
2023 (2)
2020 (9)
2000 (1)
1994 (1)
1991 (1)

Search

Sponsor content

16 result(s) found, displaying 1 to 10

TECHNESCAN SESTAMIBI kit for the preparation of technetium [99m Tc] sestamibi injection Cancelled under Section 30(1)(c) of the Act

4 July 2024

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
TECHNESCAN SESTAMIBI kit for the preparation of technetium [99m Tc] sestamibi injection Cancelled under Section 30(1)(c) of the Act

4 July 2024

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
PULMOTECH MAA Kit for the Preparation of Technetium (99mTc) albumin aggregated, aggregated albumin 2 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

17 October 2023

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
TECHNESCAN PYP Kit for preparation of Technetium (99mTc) pyrophosphate powder for injection multidose vial Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
MALLINCKRODT Gallium(67Ga) citrate 82MBq/2.2mL injection vial Cancelled under Section 30(1)(c) of the Act

19 June 2020

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
MALLINCKRODT Thallous(201Tl) chloride 85MBq/2.3mL injection vial Cancelled under Section 30(1)(c) of the Act

19 June 2020

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
MALLINCKRODT Thallous(201Tl) chloride 213MBq/5.75m L injection vial Cancelled under Section 30(1)(c) of the Act

19 June 2020

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
MALLINCKRODT Gallium(67Ga) citrate 205MBq/5.5mL injection vial Cancelled under Section 30(1)(c) of the Act

19 June 2020

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
MALLINCKRODT Gallium(Ga67) citrate 123MBq/3.3mL injection vial Cancelled under Section 30(1)(c) of the Act

19 June 2020

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd
MALLINCKRODT Thallous(201Tl) chloride 63MBq/1.7mL injection vial Cancelled under Section 30(1)(c) of the Act

19 June 2020

Cancellation by sponsor

Requested by Landauer Radiopharmaceuticals Pty Ltd

Pages

Current page 1
Page 2
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia